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Abstract
Aims: The aim of this study was to evaluate the vestibular-palatal diffusion of 4% articaine with epinephrine 
1:100,000 and 1:200,000, in impacted maxillary third molar extractions, without palatal injection. Materials and 
Method: Two hundred teeth were selected from patients age 15 to 46. Patients were divided into 4 groups: 1A, 
were anesthetized with 4% articaine 1:100,000 and the surgery was initiated 5 minutes following anesthesia. 
1B, used 4% articaine 1:100,000 but the surgery was started 10 minutes after anesthesia.  2A, used 4% articaine 
1:200,000 the surgery was started 5 minutes after. 2B, used 4% articaine 1:200,000 but 10 minutes was allowed 
for anesthetic diffusion before the initiation of in groups (50 extractions each) only buccal vestibule anesthesia 
was initially administered (i.e. no palatal injections were used). Results: The rate of sufficient vestibule-palatal 
diffusion, as determined by the lack of necessity of supplemental palatal anesthesia, was: 1A(84%), 1B(98%), 
2A(78%), 2B(82%). Chi-square (X2) and residual analyses showed that a higher vestibule-palatal diffusion was 
obtained using 4% articaine 1:100,000 with a period of 10 minutes (p<0.05). Conclusions: Most of the extractions 
could be performed only with vestibule anesthesia. However, vasoconstrictor concentration and the time interval 
between administration of the anesthetic and initiation of surgery did influence buccal vestibule-palatal diffusion 
of 4% articaine in the extraction models used.
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Introduction
Due to a dense vascularization and innervation of the 
palatal mucosa, as well as, its strong attachment to 
bone, palatal local anesthesia injections are frequently 
associated with at least some level of discomfort. In 
the search for alternatives to circumvent this problem 
a number of studies have investigated the utilization of 
articaine hydrochloride as a means of minimizing the 
use of palatal anesthesia in dentistry (1,2).
Articaine hydrochloride is an amide-type local anesthe-
tic, which is unique among clinically used local anes-
thetics in that its lipophilic moiety is a thiophene ring 
with an ester side-chain. There is at least some evidence 
suggesting that it is the local anesthetic that best diffu-
ses within soft and hard tissues (2-6). The factors that 
contribute to this however are poorly understood.
The articaine has pH of 4.4 and 5.2 associated to the 
epinephrine 1:100,000, and 4.6 and 5.4 associated to the 
epinephrine 1:200,000. The pKa is of 7.8 in both con-
centrations of vasoconstrictor and its latency to 1 of 3 
minutes (7-10). In the present research a time of latency 
of 5 and 10 minutes was allowed. These times had de-
monstrated to be necessary so that the diffusion occu-
rred to the vestibule-palatal of articaine (2,3).
Some studies have evaluated the vestibule-palatal diffu-
sion of the articaine in extractions only with the vesti-
bular anesthesia, without the palatal complementation 
(2,5,11).
The aim of this study was to evaluate the vestibular-
palatal diffusion of articaine hydrochloride 4% associa-
ted with either epinephrine 1:000,000 or epinephrine 
1:200,000 in impacted maxillary third molar extrac-
tions using only vestibule infiltrative terminal anesthe-
sia  without, therefore, palatal injections.
Materials and Methods
The following research protocol was previously appro-
ved by the Ethics Committee of the State Health’s, De-
partment of João Pessoa, Paraiba, Brazil. One was to a 
clinical research, the transversal, daily pay-experimen-
tal type, with primary data. The literature researched 
ranged throughout the years of 1987 to 2006.
Two hundred impacted maxillary third molars were se-
lected from 15 to 46 year-old patients of both sexes and 
their removal carried out using only buccal vestibule 
terminal infiltrative anesthesia (without palatal injec-
tion) with 1.8 ml of articaine hydrochloride 4% under 
the four following conditions: Group 1A-50 extractions 
utilizing articaine hydrochloride with epinephrine 
1:100,000 (Articaine® - DFL) with an  interval of 5 mi-
nutes between anesthesia and the start of surgery (time 
for anesthetic diffusion). Group 1B-50 extractions uti-
lizing articaine with epinephrine 1:100,000 with a time 
period of 10 minutes between anesthetic administration 
and initiation of surgery. Group 2A-50 extractions using 
articaine hydrochloride with epinephrine 1:200,000 
(Septanest® - SEPTODONT) and an interval of 5 mi-
nutes between anesthesia injection and commencement 
of surgical procedures and, Group 2B-50 extractions 
utilizing articaine with epinephrine (1:200,000 waiting 
for 10 minutes following anesthesia to start the extrac-
tions).
Each surgery was performed by a single operator. Ini-
tially vestibule infiltrative anesthesia was administered 
to the upper right third molar region. After a time pe-
riod of either 5 or 10 minutes the surgical procedure for 
tooth removal was initiated. The adequacy of anesthesia 
was determined at each surgical phase by the presen-
ce or absence of pain as indicated by the patient accor-
ding to a pre-established protocol. In those cases where 
pain control was not adequate by vestibule infiltration 
anesthesia alone, supplemental palatal anesthesia was 
performed and the surgical procedure continued. The 
patients were fully conscious during surgery and able to 
communicate normally. No form of systemic sedation 
or block anesthesia was utilized (2,3).
Significant differences between experimental groups 
were investigated by Chi-Square (X2) tests and residual 
analysis with a level of significance set at p< 0.05. This 
was carried out using GraphPad Prism software (Gra-
phPad Software, San Diego-CA, USA).
Results
The vestibule-palatal diffusion of articaine hydrochlori-
de 4% associated with epinephrine at two different con-
centrations (1:100,000 and 1:200,000) was compared. 
A comparison was also made relative to two different 
time intervals allowed between the administration of 
the anesthetic and start of surgery (5 and 10 minutes). 
The rate of success was determined by the number of 
extractions performed without the need for supplemen-
tal palatal injections.
The absolute numbers and percentages of extractions 
performed with and without the need for supplemental 
palatal anesthesia according to the different vasocons-
trictor concentrations and intervals between adminis-
tration of the anesthetic and initiation of surgery (time 
for anesthetic diffusion) (Table 1).
Chi-Square (X2) revealed a significant correlation bet-
ween the different anesthesia regimens and the need 
for supplemental palatal injection, Chi-Square(X2) = 
9.3023; P=0.025. The residual analysis indicated that 
in the group 1B the need for supplemental palatal in-
jection was significantly lower that in the other groups 
(P<0.01).
The frequency of the presence or absence of pain (re-
gardless of intensity or need for supplemental palatal 
injection) at each individual surgical phase according to 
the different conditions evaluated (Table 2).
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Groups Frequency Valid per-centage
Accumulative 
percentage
Group 1A
5 minutes 
1:100.000
Without palatal anesthetic supplementation 43 86,0 86,0
With palatal anesthetic supplementation 7 14,0 100,0
Total 50 100,0
Group 2A
5 minutes 
1:200.000
Without palatal anesthetic supplementation 39 78,0 78,0
With palatal anesthetic supplementation 11 22,0 100,0
Total 50 100,0
Group 1B
10 minutes 
1:100.000
Without palatal anesthetic supplementation 49 98,0 98,0**
With palatal anesthetic supplementation 1 2,0 100,0
Total 50 100,0
Group 2B
10 minutes 
1:200.000
Without palatal anesthetic supplementation 41 82,0 82,0
With palatal anesthetic supplementation 9 18,0 100,0
Total 50 100,0
Anesthetic diffusion 
time groups
Vasoconstric-
tor
Concentration
Pain at the moment 
of the operative 
procedure
Frequency
Relative fre-
quency per-
centage
Group 1A
5 minutes 1:100.000
NO PAIN
INCISION
EXTRACTION
SUTURE
39
3
4
4
78,0
6,0
8,0
8,0
Group 1B
10 minutes 1:100.000
NO PAIN
EXTRACTION
SUTURE
47
1
2
94,0
2,0
4,0
Group 2A
5 minutes 1:200.000
NO PAIN
INCISION
EXTRACTION
SUTURE
34
1
10
5
68,0
2,0
20,0
10,0
Group 2B
10 minutes 1:200.000
NO PAIN
INCISION
EXTRACTION
SUTURE
36
2
7
5
72,0
4,0
14,0
10,0
Table 1. Efficacy of articaine hydrochloride 4% vestibule-palatal diffusion  associated with epinephrine 1:100.000 or 1:200.000 
and with different time periods for anesthetic diffusion (n=200).
Table 2. Presence or absence of pain at the various surgical phases according to vasoconstrictor concentration and 
anesthetic diffusion time (n=200).
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Discussion
There are still relatively few studies that strongly subs-
tantiate the purported high vestibule–palatal diffusi-
bility of articaine hydrochloride (12-15). However the 
results of this study indicate that articaine has indeed 
high vestibule-palatal diffusion and that in fact in most 
cases supplemental palatal injection is not necessary 
(2-6,11,16).
In all groups a few patients complained of pain during 
suturing when the needle perforated the palatal mucosa. 
This pain, however, was considered mild and not one 
patient accepted supplemental palatal injection, more 
commonly citing that the latter would probably be more 
painful than the slight discomfort produced by suturing. 
The reason or reasons why these patients felt pain only 
at the suturing stage of surgery merit further investi-
gation. 
The results of this study also indicate that articaine 
hydrochloride 4% with epinephrine 1:100,000 produces 
more effective buccal vestibule-palatal anesthesia than 
the 1:200,000 solution, when an interval of 10 minutes 
is allowed between the administration of the anesthetic 
and the initiation of surgery. This strongly suggests that 
vasoconstrictor concentration may influence anesthetic 
diffusion. It may be that due to a slower absorption rate 
the anesthetic with epinephrine 1:100,000 is available 
at a higher initial concentration for diffusion (forming 
a higher concentration gradient) than the 1:200,000 so-
lution. Alternatively, the former may simply stay longer 
in the vicinity of the neural fibers leading thus to a more 
efficient pain control.
Conclusions
1. Articaine hydrochloride 4% demonstrated relatively 
good vestibule-palatal diffusion in the 4 test groups 
analysed, with efficacy rates of anesthesia of 78% (2A), 
82% (2B), 86% (1A) and 98% (1B).
2. Retained maxillary third molar extractions could be 
performed with only buccal vestibule infiltrative termi-
nal anesthesia in the majority of cases, with no need for 
supplemental palatal injections.
3. Vasoconstrictor concentration as well as the time in-
terval between anesthetic administration and start of 
surgery influenced tissue diffusion, as shown by the 
greater efficacy of the articaine hydrochloride 4% with 
epinephrine 1:100,000, 10 minutes group.
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